Janux Therapeutics News and Activities

Presence

Janux Therapeutics develops cancer medicines using targeted immunotherapy platforms. Its main products are drug candidates and research services for patients with solid tumors and for healthcare partners in oncology.

Janux Therapeutics products and services overview:

Cancer therapeutics
Immunotherapy platforms
Drug candidates
Research collaborations
Oncology programs

Revenue: ~$9 million

Employees: 140

Headquarters: San Diego, United States (USA)

Janux Therapeutics is one of the...

Janux Therapeutics is a company listed under the stock ticker JANX (US).

Executives

View the org chart displaying its 36 main executives

Most searched biographies at Janux Therapeutics

Popular executive movements at Janux Therapeutics

Judy Vong has joined the company as Vice President, Regulatory Affairs and Quality Assurance (posted on April 29 2026).
Zachariah McIver, Chief Medical Officer, has left the company (posted on January 26 2026).
William G has joined the company as Chief Medical Officer (posted on January 26 2026).

Click here to view some more movements at Janux Therapeutics

Create your alert
to follow the executive moves at Janux Therapeutics.